SREN has been the subject of a number of other research reports. Commerzbank set a CHF 95 price target on shares of Swiss Re and gave the stock a neutral rating in a research note on Tuesday, September 25th. Goldman Sachs Group set a CHF 103 price target on shares of Swiss Re and gave the stock a buy rating in a research note on Thursday, July 19th. Royal Bank of Canada set a CHF 99 price target on shares of Swiss Re and gave the stock a neutral rating in a research note on Thursday, July 12th. UBS Group reiterated a sell rating on shares of Swiss Re in a research note on Wednesday, October 10th. Finally, Societe Generale set a CHF 102 price target on shares of Swiss Re and gave the stock a buy rating in a research note on Thursday, August 30th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the company. The stock has an average rating of Hold and a consensus price target of CHF 99.34.
VTX SREN opened at CHF 97.12 on Thursday. Swiss Re has a one year low of CHF 81.65 and a one year high of CHF 98.80.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Story: How are the companies in the S&P 500 selected?
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.